Hospital News
Return to Oncology (Cancer) Overview
More on Oncology (Cancer)
- Latest Findings Presented at Second International Symposium on Pediatric Non-Hodgkin's Lymphoma
- The Seventh Issue of Cancer Prevention Has Arrived!
- New Radiation Therapy for Prostate Cancer Has Fewer Side Effects
- Smokers and Former Smokers Should Be Screened for Lung Cancer, Even if They Do not Have Symptoms
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
- Female Smokers Face Double the Risk for Lung Cancer Compared to Male Smokers, NewYork-Presbyterian/Weill Cornell Study Finds
- Multiple Myeloma Oral Therapy REVLIMID Approved by FDA
- Annual CT Screening for Lung Cancer Is Cost-Effective for High-Risk Persons, Study Finds
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Clinical Trial for a Novel Multiple Myeloma Vaccine Begins at New York Weill Cornell Medical Center
- Columbia Receives $3 Million Award From Pediatric Cancer Foundation for New Research Laboratory
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Dr. Anne Moore, New York Weill Cornell Physician, Receives Award from Lawyers' Breast Cancer Group
- Dr. Selina Chen-Kiang Honored as Researcher of the Year by the Leukemia and Lymphoma Society
- Dr. Thomas Herzog Named Director of Gynecologic Oncology at NewYork-Presbyterian Hospital/Columbia University Medical Center
- Female Smokers Twice as Likely as Men To Develop Lung Cancer, Weill Cornell Study Finds
- Gleevec May Be Effective Against a Second Blood Disease, According to Study To Be Presented at Hematology Meeting
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Helping Parents Do the Right Thing: New Guidelines on Umbilical Cord Blood Banking
- Landmark Study Reveals Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatment
- Liver Transplantation for Bile Duct Cancer Patients at NewYork-Presbyterian Hospital/Columbia University Medical Center
- Lung Cancer CT Screening Is Cost-Effective, Weill Cornell Study Shows
- Lung Cancer Screening Regimen Provides Opportunity for Cure
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Anti-Leukemia Drug Significantly Improves Survival Even for Patients With Late-Stage Disease, Study Finds
- New Book by NewYork Weill Cornell Radiologist Offers Hope to Those Who May Face Lung Cancer
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- New Comprehensive Gastrointestinal Health Center To Be Established at NewYork-Presbyterian Weill Cornell
- New Oncoplastic Surgery Combines Breast Cancer Surgery and Breast Reduction Surgery
- New Research To Address Pressing Question: Will Early Lung Cancer Detection Lead to Tobacco Cessation?
- New York-Cornell Offers New, Less Painful Treatment for Esophageal Cancer
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian/Weill Cornell Multiple Myeloma Program Begins Clinical Trial of Promising New Chemotherapy Cocktail with Revlimid
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physicians-Scientists Present Latest Cancer Findings at American Society of Hematology Meeting
- NewYork-Presbyterian Hospital Oncologists, from Columbia, Weill Cornell, Co-Lead World's Largest Lymphoma Forum for Patients
- New York Weill Cornell Researchers Report CT Screening of Patients at Risk for Lung Cancer Saves Lives
- New York Weill Cornell To Lead Statewide Consortium in Early CT Screening for Lung Cancer
- One of the Nation's Largest Portfolios of New Lymphoma Therapies Targets Diverse and Difficult Cancer
- Popular Arthritic Medication May Prevent Colon Cancer
- Potassium Iodide Should Be Available to People Living Near Nuclear Power Plants
- Robotic Prostate Surgery Study Finds 5-Year Outcomes Favorable
- Scientists Identify Cells Necessary for Tumor Angiogenesis
- Study Looks at New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Medical College Wins $7.5 Million Grant From Leukemia Society To Study Multiple Myeloma
- Weill Cornell Physician-Scientists Present Latest Cancer and Blood Findings at American Society of Hematology (ASH) Meeting
- Weill Cornell Physicians Rebut Recent Criticisms on Value of Mammography
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
- Weill Cornell Researchers Report "Encouraging" Results with First Combination Antibody Therapy for Lymphoma
Health Library
Return to Oncology (Cancer) Overview
More on Oncology (Cancer)
- Acoustic Neuromas
- Actinic Keratosis (A Precancerous Condition)
- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Adrenal Tumors
- Anal Cancer
- Angiogenesis Inhibitors
- Basal Cell Carcinoma
- Biliary Cirrhosis / Bile Duct Cancer
- Bladder Cancer
- Bone Marrow Transplantation
- Brachytherapy
- Breast Cancer: Diagnosis
- Breast Cancer: General Information
- Breast Cancer: Stages
- Breast Cancer in Men
- Breast Cancer Risk Factors
- Breast Cancer Signs and Symptoms
- Breast Cancer Statistics
- Breast Cancer Treatment
- Breast Cancer Treatment: Surgery
- Breast Reconstruction
- Cancer, Colorectal
- Cancer: Overview of Diagnostic Procedures
- Cancer Overview
- Cancer Rehabilitation
- Cancer Treatment Protocols
- Cervical Cancer
- Chemotherapy
- Chemotherapy for Breast Cancer Treatment
- Chondroblastoma
- Chondrosarcoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Cutaneous T-Cell Lymphoma
- Cytology
- Endometrial Cancer
- Esophageal Cancer
- Ewing's Sarcoma
- External Beam Therapy
- Gastrointestinal Cancers
- Giant Cell Tumor
- Glomus Jugulare Tumors
- Grading and Staging of Cancer
- Hodgkin's Disease
- Hormone Therapy
- Immunotherapy (Biological Therapy)
- Intraventricular Tumors
- Kidney Cancer
- Laryngeal Cancer (Cancer of the Larynx)
- Leukemia Overview
- Linear Accelerator (LINAC)
- Liver Tumors
- Lung Cancer
- Melanoma
- Melanoma: Diagnosis and Staging
- Meningiomas
- Merkel Cell Cancer
- Myeloma Bone Disease / Multiple Myeloma
- Non-Hodgkin's Lymphoma
- Oral Cancer
- Oral Cancer and Tobacco
- Orbital Tumors
- Osteochondroma
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Parathyroid Tumor
- Penile Cancer
- Pituitary and Parasellar Tumors
- Posterior Fossa Tumors
- Preoperative Embolization of Hypervascular Tumors
- Prostate Cancer
- Prostate Cancer: Clinical Trials
- Prostate Cancer: Expectant Therapy
- Prostate Cancer: Psychosocial Factors
- Prostate Cancer: Stages
- Prostate Cancer Grading
- Prostate Cancer in African-American Men
- Prostate Cancer Risk Factors
- Prostate Cancer Signs and Symptoms
- Prostate Cancer Statistics
- Prostate Problems: Diagnostic and Evaluation Procedures
- Prostate Surgery
- Radiation Oncology
- Radiation Oncology: Promising New Therapies
- Radiation Therapy
- Sarcoma
- Skin Cancer
- Skin Cancer: Treatment
- Skin Cancer Facts
- Skin Cancer Prevention
- Spinal Tumors (Primary, Metastatic)
- Squamous Cell Carcinoma
- Stomach Cancer
- Tamoxifen
- Taxol (paclitaxel)
- Testicular Cancer
- Thyroid Tumors
- Uterine Cancer
- Uterine Fibroids
- Vaginal Cancer
- Vulvar Cancer
Clinical Services
Return to Oncology (Cancer) Overview
More on Oncology (Cancer)
- Adult Bone Marrow Transplant
- Bladder Cancer
- Blood and Bone Marrow Transplant
- Blood Cancer
- Brain Cancer
- Breast Cancer
- Breast Center at NewYork-Presbyterian/Columbia
- Breast Centers
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Head and Neck Surgery
- Hematology (Blood Disorders)
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
- Weill Cornell Breast Center
- Women at Risk Program
Oncology (Cancer)
The Cancer Centers of NewYork-Presbyterian Hospital draw on the traditions of innovation and excellence established by the scientific and clinical endeavors of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Weill Cornell Cancer Center of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The outstanding accomplishments of these centers in all areas of cancer research, diagnosis, treatment, and prevention are world-renowned.
The Herbert Irving Comprehensive Cancer Center is one of only two National Cancer Institute-designated comprehensive cancer centers in Manhattan. It is committed to eradicating cancer through research, education, and patient care. The Center also promotes interdisciplinary laboratory, clinical, and population-based research, and facilitates the application of this research to cancer prevention, diagnosis, and treatment.
Weill Cornell Cancer Center brings together specialists in the diagnosis, treatment, and prevention of cancer, and conducts a wide range of basic science and clinical research to help make the newest and most promising cancer treatments possible.
Through the collective and coordinated efforts of the NewYork-Presbyterian Cancer Centers, patients have access to a tremendous reservoir of oncology programs led by physicians, scientists, and other health professionals dedicated to developing and expanding our knowledge in the field. In the past decade, there has been an explosion in the knowledge of how cancers develop, sustain themselves, and may be treated. As this information is translated into clinical successes, it provides us with encouragement-improvements in what we can offer patients will come more quickly and be more potent in the years to come. Many of the breakthroughs in understanding, treating, and preventing cancer will emerge from the research conducted at NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell.
The linkage of these two outstanding cancer programs provides us with unprecedented opportunities for collaborative research, enhanced patient care, and progress in prevention. Guiding these efforts is concern for our patients and their families. The next decade is sure to see innovative and exciting approaches to cancer care and the NewYork-Presbyterian Cancer Centers will be at the forefront, providing the expertise to save lives, the resources to enhance recovery, and the compassion that underlies all that we do toward our goal of conquering cancer.